View on Pubmed.gov 38358171 | View on doi.org 10.4103/aam.aam...
Single-Dose enoxaparin for portomesenteric venous thrombosis prophylaxis after sleeve gastrectomy.
- Department of General Surgery and Anesthesia, Faculty of Medicine, Mutah University, Karak, Jordan.
- Department of Internal Medicine, Faculty of Medicine, Mutah University, Karak, Jordan.
- Department of General Surgery, Faculty of Medicine, University of Jordan, Amman, Jordan.
- Division of Radiology, Faculty of Medicine, Mutah University, Karak, Jordan.
- Department of General Surgery, Al Karak Governmental Hospital, Karak, Jordan.
- Department of General Surgery, Jordan University Hospital, Amman, Jordan.
Abstract
Introduction
Portomesenteric venous thrombosis (PMVT) may complicate sleeve gastrectomy. We believe that single dose of enoxaparin postoperatively can reduce the risk of PMVT.
Objective
The objective was to study the outcomes of enoxaparin single dose compared to other perioperative prophylactic doses in preventing PMVT.
Methods
Participants included 590 patients who underwent laparoscopic sleeve gastrectomy (LSG). These retrospective cohort data were collected from patient medical charts after bariatric surgery. Patients were followed up in the close postoperative period and at 1, 3, 6, 12, and 18 months. Descriptive statistical analysis was carried out. The objective was to estimate the incidence of PMVT with postoperative single 40 mg subcutaneous enoxaparin prophylactic regimen.
Results
From January 2017 to December 2021, 590 patients with obesity underwent LSG. Five patients developed PMVT with an estimate incidence of 0.85%. Three patients had unexplained tachycardia and three patients had postoperative bleeding.
Conclusions
Single-dose enoxaparin 40 mg is an effective thrombosis prophylaxis without increasing risk of bleeding.
References
Surg Obes Relat Dis. 2012 Jan-Feb;8(1):108-15
Obes Surg. 2017 Sep;27(9):2360-2369
World J Surg. 2002 Apr;26(4):470-3
Ann Pharmacother. 2018 Sep;52(9):898-909
Conflict of interest statement
None
MeSH
- •
- •
- •
- •
- •
- •
Specialties
- •
- •
- •
- •
Substances
- •